VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $429,780 | -19.9% | 15,971 | -10.4% | 0.03% | -18.8% |
| Q2 2023 | $536,500 | -9.3% | 17,818 | -2.5% | 0.03% | -13.5% |
| Q1 2023 | $591,423 | +113416.9% | 18,282 | +0.6% | 0.04% | +12.1% |
| Q4 2022 | $521 | -99.8% | 18,169 | +78.0% | 0.03% | +83.3% |
| Q3 2022 | $246,000 | -14.3% | 10,208 | -2.5% | 0.02% | -10.0% |
| Q2 2022 | $287,000 | -28.4% | 10,472 | +0.3% | 0.02% | -23.1% |
| Q1 2022 | $401,000 | +17.6% | 10,442 | -1.9% | 0.03% | +18.2% |
| Q4 2021 | $341,000 | +9.3% | 10,648 | +0.6% | 0.02% | 0.0% |
| Q3 2021 | $312,000 | -13.1% | 10,584 | 0.0% | 0.02% | -12.0% |
| Q2 2021 | $359,000 | -0.3% | 10,584 | -4.4% | 0.02% | -3.8% |
| Q1 2021 | $360,000 | -3.2% | 11,073 | +7.3% | 0.03% | -10.3% |
| Q4 2020 | $372,000 | -14.7% | 10,315 | -7.4% | 0.03% | -21.6% |
| Q3 2020 | $436,000 | -4.4% | 11,139 | -10.4% | 0.04% | -9.8% |
| Q2 2020 | $456,000 | +27.7% | 12,429 | -19.8% | 0.04% | +13.9% |
| Q1 2020 | $357,000 | -47.9% | 15,488 | -33.8% | 0.04% | -35.7% |
| Q4 2019 | $685,000 | -20.7% | 23,401 | -26.2% | 0.06% | -29.1% |
| Q3 2019 | $864,000 | -4.6% | 31,722 | -10.5% | 0.08% | -12.2% |
| Q2 2019 | $906,000 | +285.5% | 35,429 | +238.4% | 0.09% | +260.0% |
| Q1 2019 | $235,000 | -72.1% | 10,471 | -73.8% | 0.02% | -75.7% |
| Q4 2018 | $842,000 | +249.4% | 39,913 | +207.1% | 0.10% | +255.2% |
| Q3 2018 | $241,000 | -16.3% | 12,997 | +0.5% | 0.03% | -21.6% |
| Q2 2018 | $288,000 | +1.4% | 12,927 | -0.0% | 0.04% | -2.6% |
| Q1 2018 | $284,000 | +2.5% | 12,931 | +8.6% | 0.04% | +5.6% |
| Q4 2017 | $277,000 | +4.1% | 11,902 | +2.9% | 0.04% | -10.0% |
| Q3 2017 | $266,000 | +0.4% | 11,566 | -3.5% | 0.04% | -2.4% |
| Q2 2017 | $265,000 | -7.3% | 11,989 | -4.5% | 0.04% | -8.9% |
| Q1 2017 | $286,000 | -3.4% | 12,559 | -11.2% | 0.04% | -4.3% |
| Q4 2016 | $296,000 | -22.5% | 14,145 | -2.1% | 0.05% | -28.8% |
| Q3 2016 | $382,000 | -12.6% | 14,452 | -8.3% | 0.07% | +73.7% |
| Q2 2016 | $437,000 | – | 15,764 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |